Cardiovascular

Still in Shock! Challenges and Controversies in Refractory Shock Management

Concurrent Session Moderator(s)

• 

  Seth Bauer, PharmD, FCCM (he/him/his)

  Cleveland Clinic Foundation

Refractory shock impacts a variety of ICU patient populations, requiring significant resource use and compromising patient outcomes. This session will explore the challenges and controversies associated with defining and managing refractory shock, including the limitations of characterizing refractory shock, novel biomarkers used in diagnosis, and mechanical and pharmacologic therapies.

Presentations:

• 4:35pm – 4:50pm Eastern Time

  Application of Non-Vasopressor Adjunctive Therapies and Support Devices in Refractory Shock Management
  

  Carlos Alviar, MD (he/him/his) – NYU Grossman School of Medicine
• 4:50pm – 5:05pm Eastern Time

  Defining Refractory Shock and Its Complications: The Role of Novel Diagnostic Modalities
  

  Ashish K. Khanna, MD, MS, FASA, FCCM – Atrium Health Wake Forest Baptist Medical Center
• 5:05pm – 5:20pm Eastern Time

  Rationale Behind Vasopressor Selection and Utilization
  

  Pansy Elsamadisi, BCCCP, BCPS, PharmD – Beth Israel Deaconess Medical Center